User name

Don't have a user name yet?
Register here.


Slovenian Pharma Stock Underpriced, Say KAD and SOD

Ljubljana, 19 September - The largest individual stock holders of the Ljubljana pharmaceutical Lek, the Pension Fund Management (KAD) and the Restitution Fund (SOD), will not back the changes to Lek's company statute at the assembly on 27 September unless Swiss buyer Novartis decides to offer a higher takeover price than it has been announced. KAD and SOD informed the public of their decision at a news conference on Thursday.

© STA, 2002